MB
McKelligon Brian
首席执行官
C-suiteM
内部人交易记录
首席执行官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by McKelligon Brian, 首席执行官. Officer active across 1 company, notably Akoya Biosciences, Inc.. In total, 24 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €61k. History available since 15 June 2022. The latest transaction was disclosed on 23 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to McKelligon Brian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报24 总计
393,338 股Common StockSEC:0001062993-25-012730:0
7,550 股@ US$1.706.2% 占其流量Common StockSEC:0001062993-25-006291:0
7,550 股@ US$1.636.2% 占其流量Common StockSEC:0001062993-25-004348:0
218,750 股0Common StockSEC:0001062993-24-019518:0
7,500 股@ US$0.3031.1% 占其流量Common StockSEC:0001104659-24-070825:0
7,500 股@ US$0.3031.1% 占其流量Common StockSEC:0001104659-24-069821:0
7,135 股@ US$4.7916.5% 占其流量Common StockSEC:0001104659-24-038489:0
7,500 股@ US$0.3031.1% 占其流量Common StockSEC:0001104659-24-037977:0
7,500 股@ US$0.3031.1% 占其流量Common StockSEC:0001104659-24-037978:0
7,500 股@ US$4.93817.8% 占其流量Common StockSEC:0001104659-24-034668:0
87,500 股0Common StockSEC:0001104659-24-030186:0
87,500 股0Common StockSEC:0001104659-24-030164:0
7,500 股@ US$0.3031.1% 占其流量Common StockSEC:0001104659-23-127810:0
7,500 股@ US$0.3031.1% 占其流量Common StockSEC:0001104659-23-126041:0
7,500 股@ US$0.3031.1% 占其流量Common StockSEC:0001104659-23-120723:0
5,000 股@ US$0.3030.7% 占其流量Common StockSEC:0001104659-23-068652:0
5,000 股@ US$5.707414.0% 占其流量Common StockSEC:0001104659-23-068652:1
7,437 股@ US$7.6927.7% 占其流量Common StockSEC:0001104659-23-037252:0
5,000 股@ US$0.3030.7% 占其流量Common StockSEC:0001104659-23-033335:0
80,000 股0Common StockSEC:0001104659-23-026066:0
5,000 股@ US$0.3030.8% 占其流量Common StockSEC:0001104659-22-125478:0
5,000 股@ US$0.3030.8% 占其流量Common StockSEC:0001104659-22-098890:0
5,000 股@ US$0.3030.8% 占其流量Common StockSEC:0001104659-22-072385:0
80,000 股Common StockSEC:0001104659-22-038234:0
About McKelligon Brian
McKelligon Brian is Chief Executive Officer and has 24 filings. In the 24 most recent sampled filings, there are no buys, sales total EUR 60566, the period runs from 2022-03-25 to 2025-07-10, and the most common transaction nature is Exercise of options. His largest filings include EUR 52611.28421410576 on 2023-03-27, EUR 33890.72758047563 on 2024-03-14, and EUR 31463.36753396891 on 2024-03-25, all tied to Akoya Biosciences, Inc.